Over the last few years, the single-cell landscape has transitioned from mapping individual cellular transcriptomes to ...

The global multiomics market, valued at $3.41 billion in 2025, is forecast to reach $12.82 billion by 2036, growing at a 13.31% CAGR from 2026 to 2036. Growth is driven by precision medicine, ...

OmicsBox 4.0 adds cloud integration, advanced transcriptomics tools like gene co-expression, and AI-powered summaries ...

Novogene Europe, a multiomics research services partner, today announced that it has strengthened its position as a ...

Novogene Europe, a multiomics research services partner, says it has strengthened its position as a multiomics partner with ...

A chemical called 6PPD-quinone (6PPD-Q), which forms when shaved-off tire particles come into contact with ozone, might interfere with the inner workings of brain cells, leading to Alzheimer's disease ...

RNA sequencing (RNA-seq) is a powerful transcriptomics approach for measuring differential gene expression (DGE) across the genome with remarkable sensitivity and scale. Yet conventional RNA-seq ...

The Monash Genomics & Bioinformatics Platform (formerly Micromon Genomics) is a specialist facility providing expertise in advanced DNA and RNA technologies, with sequencing—both Sanger and ...

Dr. Stephen Yi is Founding Director, Center for AI and Biomedical Discovery (AIBD), at Neuroscience Institute, Baylor College of Medicine. He is also Director of Bioinformatics at Baylor Research ...

A group of a few dozen colorful translucent 3D blobs, many of which overlap, contain brightly colored dots against a black background. Three-dimensional transcriptomics data from an instrument ...

We provide a suite of DNA sequencing and computational services to a broad client base; from small-scale Sanger sequencing to large-scale projects using next-generation sequencing technologies. We ...